Compound News and Research

RSS

Super chow, laced with semi-synthetic vitamin E derivative, inhibited spread of cancer in mice

A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.

2 Oct 2006

Simultaneous synthesis and screening in a microfluidics device

In the quest for new methods to synthesize large numbers of drug leads, medicinal chemists are increasingly turning to microfluidics as a means of performing dozens of chemical reactions using minute quantities of chemical reagents.

From Siemens Healthineers 2 Oct 2006

Insulin receptor stops progression of Alzheimer's disease

Stimulation of a receptor in the brain that controls insulin responses has been shown to halt or diminish the neurodegeneration of Alzheimer's disease, providing evidence that the disease can be treated in its early stages, according to a study by researchers at Rhode Island Hospital and Brown Medical School.

21 Sep 2006

Nitric oxide helps pregnant women with hypertension

Nitric oxide (NO) is best known as an air pollutant produced by vehicle emissions and power plants but for pregnant women it is a crucial compound required to avoid hypertension and pre-eclampsia.

21 Sep 2006

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006

Bristol-Myers Squibb and Medivira announce collaboration to commercialize HIV treatment

Bristol-Myers Squibb and Medivir AB have announced a worldwide collaboration to develop and commercialize MIV-170, a preclinical non-nucleoside reverse transcriptase inhibitor, or NNRTI, intended for the treatment of HIV-1 infection in adults as part of an antiretroviral drug regimen.

13 Sep 2006

Brown seaweed with anti-obesity potential!

Scientists believe they may have found something to combat obesity and it may also help prevent the onset of diabetes.

12 Sep 2006

Synthetic low-density lipoprotein-like nanoparticles target brain tumors

Low-density lipoprotein, better known as LDL, is one of the chief villains involved in the development of coronary artery disease.

12 Sep 2006

Reactive oxygen species in cancer cells

A biochemical alteration that has long been viewed as an adverse aspect of tumor biology may turn out to be a deadly double-edged sword for the cancer cells themselves.

12 Sep 2006

Targeted nanoparticles to improve Boron-Neutron capture therapy

Boron-neutron capture therapy (BNCT) is an experimental treatment for virulent brain cancer that aims to kill malignant cells by generating high-energy alpha particles inside tumors.

5 Sep 2006

New test for acetaminophen poisoning

A new test for acetaminophen poisoning is effective with children as well as adults, according to a study published this month by researchers at the University of Arkansas for Medical Sciences (UAMS) and the Arkansas Children's Hospital Research Institute (ACHRI).

5 Sep 2006

Indian woman infected with HIV forced to abort her own baby

According to officials in India, a pregnant HIV-positive woman was forced to abort her own foetus after doctors and nurses in the government hospital in Kolkata in eastern India, shunned her and told her they would not help her undergo an abortion.

5 Sep 2006

Edible coatings will be the packaging of the future

The growing demand by consumers for healthier and more ecological foods has driven researchers to develop new systems of packaging that prolong the useful life of the products and that are, at the same time, recyclable.

4 Sep 2006

Ranbaxy wins two additional Atorvastatin patents in Norway

Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.

30 Aug 2006

Obesity affects survival odds for ovarian cancer

According to research in the U.S. obese women get more aggressive ovarian cancers, have a shorter time before the cancer recurs and a shorter survival compared to women who are not obese.

29 Aug 2006

Scientists trick cancer cells into suicide

Scientists in the U.S. believe they have found a way to trick cancer cells into committing suicide.

28 Aug 2006

St. John's wort and polymeric nanoparticles to treat ovarian tumors using light

By combining a compound produced by the plant St. John's wort with polymeric nanoparticles, researchers at the University of Geneva in Switzerland have developed a promising method for treating ovarian tumors using light.

21 Aug 2006

New findings support Rapamycin's role as cancer treatment

Scientists have long known that the blood vessels of tumors differ markedly from normal blood vessels.

14 Aug 2006

Ancient blue war paint from plant rich in cancer fighting compound

Glucobrassicin, a compound in plants which is known to be an anti-cancer agent has been discovered in a plant that gave ancient Britons and Celts their blue war paint.

14 Aug 2006

Boston Life Sciences announces issuance of U.S. patent for methods to diagnose ADHD

Boston Life Sciences has announced that the U.S. Patent and Trademark Office has issued a patent to the President and Fellows of Harvard College, the General Hospital Corporation and Organix that covers methods of diagnosing and monitoring attention deficit hyperactivity disorder (ADHD) by assessing the level of dopamine transporter (DAT) in at least one region of a patient's central nervous system.

14 Aug 2006